- Trials with a EudraCT protocol (26,165)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
26,165 result(s) found for: n.a..
Displaying page 1,067 of 1,309.
EudraCT Number: 2012-002819-26 | Sponsor Protocol Number: 181 | Start Date*: 2013-06-26 | ||||||||||||||||
Sponsor Name:CENTRO DI RIFERIMENTO ONCOLOGICO DI BASILICATA | ||||||||||||||||||
Full Title: FMISO F18 PET/CT as marker of hypoxia in patients undergoing radio- and chemotherapy | ||||||||||||||||||
Medical condition: Patients complying with tumours and undergoing radio- and/or chemotherapy for whom is mandatory to know the hypoxia component | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: IT (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-004955-35 | Sponsor Protocol Number: 1883/12 | Start Date*: 2013-07-29 | |||||||||||
Sponsor Name:POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI | |||||||||||||
Full Title: A single-center randomized double-blind placebo-controlled trial “Treatment of Systemic Sclerosis with Rituximab: evaluation of the effectiveness of B-cell depletion therapy” | |||||||||||||
Medical condition: SYSTEMIC SCLEROSIS | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-002872-15 | Sponsor Protocol Number: 1203/12 | Start Date*: 2012-09-13 | |||||||||||
Sponsor Name:POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI | |||||||||||||
Full Title: Hyperthermic intra-peritoneal chemotherapy (HIPEC) in Ovarian cancer recurrence: Randomized trial on Survival Evaluation. | |||||||||||||
Medical condition: Ovarian cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-000208-41 | Sponsor Protocol Number: TV1380-COA-201 | Start Date*: 2013-09-17 | |||||||||||
Sponsor Name:Teva Pharmaceutical Industries Ltd. | |||||||||||||
Full Title: A 12-week, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Once-Weekly Intra-Muscular Injections of TV-1380 (150 mg/week or 30... | |||||||||||||
Medical condition: Treatment for Facilitation of Abstinence in Cocaine-Dependent Subjects | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-000939-42 | Sponsor Protocol Number: IP-N02 | Start Date*: 2012-07-20 | |||||||||||
Sponsor Name:Elro Pharma | |||||||||||||
Full Title: A non-randomized, open-label, multi-centric dose-finding adaptive phase I/IIa study to assess safety, tolerability, pharmacokinetics and preliminary efficacy of repeated intravenous IPP-204106N adm... | |||||||||||||
Medical condition: Solid tumors | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-016853-16 | Sponsor Protocol Number: MGN1601-CT1 | Start Date*: 2010-08-31 | |||||||||||
Sponsor Name:MOLOGEN AG | |||||||||||||
Full Title: A Phase I/II, Proof-of-Principle, Multi-Center, Open-Label, Single-Arm, Non-randomized Clinical Study to Assess Safety and Efficacy of a Tumor Vaccine Consisting of Genetically Modified Allogeneic ... | |||||||||||||
Medical condition: Advanced renal cell carcinoma | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-001438-27 | Sponsor Protocol Number: 48885 | Start Date*: 2015-08-19 |
Sponsor Name:Academic Medical Center | ||
Full Title: The effect of bezafibrate on cholestatic itch | ||
Medical condition: Primary biliary cirrhosis (PBC) Primary sclerosing cholangitis (PSC) Secondary sclerosing cholangitis (SSC) | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Ongoing) ES (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2014-005548-17 | Sponsor Protocol Number: 69HCL14-0438 | Start Date*: 2015-04-28 | |||||||||||
Sponsor Name:HOSPICES CIVILS DE LYON | |||||||||||||
Full Title: TREATMENT OF PENDULAR NYSTAGMUS WITH GABAPENTIN AND MEMANTINE IN PATIENTS WITH MULTIPLE SCLEROSIS or OCULOPALATAL TREMOR: A CONTROLED OPEN-LABEL STUDY | |||||||||||||
Medical condition: PENDULAR NYSTAGMUS IN PATIENTS WITH MULTIPLE SCLEROSIS OR OCULOPALATAL TREMOR | |||||||||||||
|
|||||||||||||
Population Age: | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-005542-23 | Sponsor Protocol Number: CR0708-11 | Start Date*: 2009-07-27 | |||||||||||
Sponsor Name:Cancer Research UK | |||||||||||||
Full Title: A CCLG/Cancer Research UK Phase I Trial of AT9283 (a selective inhibitor of Aurora kinases) given for 72 hours every 21 days via intravenous infusion in children and adolescents with relapsed and r... | |||||||||||||
Medical condition: Relapsed and refractory solid tumours in children and adolescents | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-002344-16 | Sponsor Protocol Number: RR16/209 | Start Date*: 2018-06-28 |
Sponsor Name:University of Leeds | ||
Full Title: Targeted treatment early with etanercept (biosimilar) plus methotrexate or methotrexate with T2T care for DMARD-naïve early RA patients. A prospective, longitudinal cohort study with an embedded pi... | ||
Medical condition: Rheumatoid Arthritis | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (GB - no longer in EU/EEA) | ||
Trial results: (No results available) |
EudraCT Number: 2017-000664-14 | Sponsor Protocol Number: 16178SE-AS | Start Date*: 2018-02-06 |
Sponsor Name:Belfast Health and Social Care Trust | ||
Full Title: A 2x2 factorial randomised examiner blind open label trial to determine the CLinical and cost- Effectiveness of hypertonic saline (HTS 6%) and carbocisteine for Airway cleaRance versus usual care o... | ||
Medical condition: Bronchiectasis | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (GB - no longer in EU/EEA) | ||
Trial results: (No results available) |
EudraCT Number: 2017-001481-23 | Sponsor Protocol Number: P160927J | Start Date*: 2017-09-12 | |||||||||||
Sponsor Name:ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP) | |||||||||||||
Full Title: MULTICENTER, RANDOMIZED, DOUBLE BLIND, PLACEBO CONTROLLED CLINICAL TRIAL WITH RILUZOLE IN SPINOCEREBELLAR ATAXIA TYPE 2 | |||||||||||||
Medical condition: SCA2 patients, both gender, at least 18 years of age | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-002352-24 | Sponsor Protocol Number: | Start Date*: 2016-08-02 | |||||||||||
Sponsor Name:Imperial College Healthcare NHS Trust | |||||||||||||
Full Title: Safety of Nasal Influenza Immunisation in Children with Asthma: The SNIFFLE 4 study | |||||||||||||
Medical condition: Children aged 2-18 years (inclusive), with asthma / recurrent wheezing. | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-004076-13 | Sponsor Protocol Number: 5 | Start Date*: 2006-11-28 |
Sponsor Name:Huvud- hals- lung- och hudcancer, Tema Cancer Karolinska Universitetssjukhuset | ||
Full Title: Secar I Part I: A study of MTD of Sodium selenite in patients with advanced carcinoma. A phase I study. Amendment 5: continuous treatment | ||
Medical condition: Patients with stage III or IV cancer in whom first and second line treatment have been given but who have tumours that are still progressing, giving symptomes. The patients must be in a fairly good... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: SE (Restarted) | ||
Trial results: (No results available) |
EudraCT Number: 2018-000970-31 | Sponsor Protocol Number: CV013-034 | Start Date*: 2018-09-10 | ||||||||||||||||
Sponsor Name:Bristol-Myers Squibb International Corporation | ||||||||||||||||||
Full Title: A Randomized, Double-Blind, Placebo-Controlled, Cross-over Phase 2 Study of Continuous 8 Hour Intravenous Infusions of BMS-986231 in Patients with Heart Failure and Impaired Systolic Function Given... | ||||||||||||||||||
Medical condition: Heart failure with reduced ejection fraction (HFrEF) | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2019-004101-27 | Sponsor Protocol Number: INDIGO | Start Date*: 2020-01-15 | |||||||||||||||||||||
Sponsor Name:Sint Maartenskliniek | |||||||||||||||||||||||
Full Title: INDIGO: Comparing pharmacokinetic parameters of golimumab 50 mg and golimumab 100 mg with a prolonged dose interval in patients with a rheumatic disease, a within-subject controlled study’ | |||||||||||||||||||||||
Medical condition: rheumatoid arthritis, psoriatic arthritis, axial spondyloarthritis | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: NL (Ongoing) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-000099-41 | Sponsor Protocol Number: AC18082 | Start Date*: 2019-10-02 | |||||||||||
Sponsor Name:University of Edinburgh [...] | |||||||||||||
Full Title: Motor Neurone Disease Systematic Multi-arm Adaptive Randomised Trial (MND-SMART) | |||||||||||||
Medical condition: Motor Neurone Disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-002453-11 | Sponsor Protocol Number: CFTSp116 | Start Date*: 2018-01-19 | |||||||||||
Sponsor Name:The Christie NHS Foundation Trust | |||||||||||||
Full Title: A multi-centre, randomised, parallel group, open-label, phase II, single-stage selection trial of nanoliposomal irinotecan (nal-IRI) and 5-fluorouracil (5-FU)/folinic acid or docetaxel as second-li... | |||||||||||||
Medical condition: Poorly differentiated extra-pulmonary neuroendocrine carcinoma | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-001216-19 | Sponsor Protocol Number: | Start Date*: 2014-11-13 |
Sponsor Name:NHS Greater Glasgow & Clyde [...] | ||
Full Title: Short-course radiotherapy plus olaparib for newly diagnosed glioblastoma in patients unsuitable for radical chemoradiation: a randomised phase II clinical trial preceded by a lead-in phase I dose e... | ||
Medical condition: glioblastoma | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (GB - no longer in EU/EEA) | ||
Trial results: (No results available) |
EudraCT Number: 2011-004351-39 | Sponsor Protocol Number: FARM8MXYFL | Start Date*: 2011-10-28 | |||||||||||||||||||||
Sponsor Name:AZIENDA UNIVERSITARIA POLICLINICO UMBERTO I DI ROMA | |||||||||||||||||||||||
Full Title: Phase II, randomized, double arm, multi-center study evaluating the efficacy and safety of azithromycin for the long term prophylactic treatment of COPD in primary antibody deficiency patients with... | |||||||||||||||||||||||
Medical condition: primary immunodefciency patients with COPD and frequent exacerbations | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.